Najnowsze wersje próbne

EudraCT Number: 2010-018940-15

Sponsor Protocol Number: FLDX-001

Start Date:

Sponsor Name: SALUS Haus GmbH & Co. KG

Full Title: A Phase IV, multi-centre, randomized, open label study to investigate the efficacy and safety of Floradix® mit Eisen and ferro sanol® duodenal mite 50 mg in pregnant women with diagnosed iron defic...

Medical condition: Pregnant women with diagnosed iron deficiency

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10022976	Iron deficiency anemia secondary to inadequate dietary iron intake	LLT

Population Age: Adults

Gender: Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2020-003010-12

Sponsor Protocol Number: APHP180600

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title: «Efficacy of Fluticasone Propionate associated with Salmeterol using inhalation chamber versus placebo to improve the respiratory function in children over six years of age who underwent allogeneic...

Medical condition: Bronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT). .

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-004494-27

Sponsor Protocol Number: 5020DERM-2018

Start Date:

Sponsor Name: Landeskrankenhaus Salzburg

Full Title: pilotstudy- efficacy of infectoscab 5% creme in patients with scabies

Medical condition: Scabies

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10021881 - Infections and infestations	10039511	Scabies	LLT
	20.0	10021881 - Infections and infestations	10063409	Acarodermatitis	PT

Population Age: Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-004933-19

Sponsor Protocol Number: DROPROP1

Start Date:

Sponsor Name: Region Västra Götaland, Sahlgrenska Universitetssjukhuset

Full Title: A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematurity

Medical condition: Retinopathy of Prematurity

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	100000004853	10036858	Proliferative retinopathy	LLT

Population Age: Preterm newborn infants, Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: SE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-004617-12

Sponsor Protocol Number: INTEGRATE_IIb

Start Date:

Sponsor Name: Australasian Gastro-Intestinal Trials Group (AGITG)

Full Title: INTEGRATE IIb - A Randomised Phase III Open Label Study of regorafenib + nivolumab vs standard chemotherapy in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Medical condition: refractory, advanced gastro-oesophageal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062878	Gastrooesophageal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-002324-92

Sponsor Protocol Number: P150904

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title: Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children (NEPHROVIR3)

Medical condition: Sensitive nephrotic syndrome in children

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.1	10038359 - Renal and urinary disorders	10029164	Nephrotic syndrome	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000195-13

Sponsor Protocol Number: V59P5

Start Date:

Sponsor Name: Novartis Vaccines and Diagnostics

Full Title: A Phase II, Randomized, Open label, Controlled, Multicenter Study to Evaluate the Safety, Immunogenicity and Induction of Immunological Memory after Two or Three Doses of Novartis Meningococcal ACW...

Medical condition: Prevention of invasive disease caused by Neisseria Meningitidis serogroup A, C, W-135 and Y

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2019-003842-34

Sponsor Protocol Number: MK-5592-127

Start Date:

Sponsor Name: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc

Full Title: A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formul...

Medical condition: Invasive Fungal Infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10021881 - Infections and infestations	10017533	Fungal infection	PT

Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing) Outside EU/EEA BE (Ongoing) GR ()

Trial results: (No results available)

EudraCT Number: 2004-002050-66

Sponsor Protocol Number: PENTA 11

Start Date:

Sponsor Name: PENTA Foundation

Full Title: Treatment Interruption in Children with Chronic HIV-Infection: the TICCH Trial

Medical condition: Infected with Human Immunodeficiancy Virus - (HIV-Infection)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IE (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-008435-29

Sponsor Protocol Number: 3082B2-4433-WW

Start Date:

Sponsor Name: Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company

Full Title: A Non-Randomized, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of ReFacto AF in Previously Treated Pediatric Subjects Less Than Twelve Years of Age With Severe Hemophilia...

Medical condition: Severe hemophilia A (FVIII:C

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10010331 - Congenital, familial and genetic disorders	10018937	Haemophilia A	LLT

Population Age: Children, Under 18

Gender: Male

Trial protocol: FR (Completed) ES (Completed) IT (Completed) GR (Completed) CZ (Completed) SE (Completed) DK (Completed) FI (Completed) BG (Completed)

Trial results: View results

Najnowsze wersje próbne

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe